ADCT
ADC Therapeutics·NYSE
--
--(--)
--
--(--)
ADCT fundamentals
ADC Therapeutics (ADCT) Revenue Breakdown: Q3 2025 Business & Regional Performance
ADC Therapeutics (ADCT) reported total revenue of 16.43M USD in Q3 2025, with its core business segment Product contributing 95.88%. Regionally, United States remained the largest market, accounting for 95.88% of total revenue. Explore ADC Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
ADC Therapeutics (ADCT) reported total revenue of 16.43M USD in Q3 2025, with its core business segment Product contributing 95.88%. Regionally, United States remained the largest market, accounting for 95.88% of total revenue. Explore ADC Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for ADC Therapeutics next quarter?What factors drove the changes in ADC Therapeutics's revenue and profit?What is ADC Therapeutics's latest dividend and current dividend yield?What is ADC Therapeutics's gross profit margin?What were the key takeaways from ADC Therapeutics's earnings call?Did ADC Therapeutics beat or miss consensus estimates last quarter?What does ADC Therapeutics do and what are its main business segments?What guidance did ADC Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
